← Return to FDA HRT News

Discussion
debbie1956 avatar

FDA HRT News

Osteoporosis & Bone Health | Last Active: 1 day ago | Replies (16)

Comment receiving replies
Profile picture for janieben @janieben

@debbie1956 Thank you for your post. I read the study; I may be wrong, but I believe it focuses on women who are CONTINUING estrogen therapy past 65, not just starting it. I believe it also focuses on estrogen, not estradiol, and on oral rather than transdermal. This is the only line that actually commented on women over 65: "Dr. Streicher says women who would like to start HT after 65 should be counseled on individual risks and after cardiac health is evaluated. But, she notes, this study did not address that." Most articles reference the WHI study, which uses oral estrogen, not transdermal estradiol, and progestogen rather than micronized progesterone. So...still looking for that article. 🙂 Thank you again for your sharing of your knowledge.

Jump to this post


Replies to "@debbie1956 Thank you for your post. I read the study; I may be wrong, but I..."

@janieben I may have previously posted this podcast with Dr. Lauren Streicher you quoted from the Medscape article. My Menopause Society naturopath physician suggested Dr. Streicher's podcast when I began BHRT at age 67. She did the risk assessments mentioned by Dr. James Simon interviewed on the podcast: https://podcasts.apple.com/za/podcast/hormone-therapy-after-age-60-with-dr-james-simon/id1615785832?i=1000652082001